z-logo
open-access-imgOpen Access
Preparation and evaluation of oral capsules containing apigenin nanocrystals prepared by ultrasonication
Author(s) -
Mahmood A. Haiss,
Nidhal K. Maraie
Publication year - 2022
Publication title -
almustansiriya journal of pharmaceutical sciences/al-mustansiriyah journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
eISSN - 2959-183X
pISSN - 1815-0993
DOI - 10.32947/ajps.v21i3.793
Subject(s) - sonication , diluent , bioavailability , microcrystalline cellulose , nanocrystal , poloxamer , materials science , dissolution , poloxamer 407 , nuclear chemistry , absorption (acoustics) , chromatography , microcrystalline , anhydrous , chemical engineering , chemistry , nanotechnology , organic chemistry , cellulose , polymer , pharmacology , medicine , composite material , engineering , copolymer , crystallography
This work aims to enhance dissolution rate, increase absorption and bioavailability of Apigenin by formulating it as nanocrystal suspension employing ultrasonic technology. Two different diluents; (5%, 10%) microcrystalline cellulose (MCC) and (2%, 3%) anhydrous lactose were used to prepare hard gelatin capsules for two optimum types for apigenin nanocrystals prepared in our laboratory utilizing ultrasonication technique using 1% tween 80 (F6) and 2% poloxamer 188 (F20). The results showed that the marketed capsules (containing MCC) had about half the dissolution rate than all the prepared nanocrystals capsules formulas, and the nanocrystals prepared with poloxamer gave 90% release within 20 minutes and 100% release with 2 hours with excellent flow properties with no effect of the added diluents while the addition of diluents improved significantly the release of nanocrystals capsules (F6) with 1% tween 80 with good flow properties. The results suggested that utilizing apigenin nanocrystals prepared by ultrasonication technique may improve drug absorption and bioavailability with a reduced required dose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here